InsiderTrades.com logo

VKTX Insider Trading

Insider Ownership Percentage: 4.10%
Insider Buying (Last 12 Months): $29,946.00
Insider Selling (Last 12 Months): $16,970,187.39

Viking Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Viking Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Viking Therapeutics Share Price & Price History

Current Price: $28.44
Price Change: ▲ Price Increase of +2.15 (8.18%)
As of 02/6/2026 05:00 PM ET

This chart shows the closing price history over time for VKTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Viking Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2026Brian LianCEOSell233,409$32.96$7,693,160.642,499,291View SEC Filing Icon  
1/5/2026Greg ZanteCFOSell57,661$32.90$1,897,046.90189,891View SEC Filing Icon  
1/5/2026Marianna ManciniCOOSell57,661$32.98$1,901,659.78409,190View SEC Filing Icon  
1/2/2026Matthew W. FoehrDirectorSell16,000$35.11$561,760.00132,036View SEC Filing Icon  
10/28/2025Brian LianCEOSell38,989$35.01$1,365,004.892,419,109View SEC Filing Icon  
10/28/2025Greg ZanteCFOSell6,185$35.00$216,475.00173,592View SEC Filing Icon  
10/28/2025Marianna ManciniCOOSell6,185$35.00$216,475.00382,467View SEC Filing Icon  
10/27/2025Charles A. Rowland, Jr.DirectorSell60,000$35.57$2,134,200.0030,000View SEC Filing Icon  
7/3/2025Brian LianCEOSell26,889$27.80$747,514.202,388,014View SEC Filing Icon  
7/3/2025Greg ZanteCFOSell4,266$27.76$118,424.16168,660View SEC Filing Icon  
7/3/2025Marianna ManciniCOOSell4,266$27.77$118,466.82377,535View SEC Filing Icon  
3/31/2025Sarah Kathryn RouanDirectorBuy1,240$24.15$29,946.001,240View SEC Filing Icon  
1/6/2025Brian LianCEOSell194,490$42.75$8,314,447.502,366,570View SEC Filing Icon  
1/6/2025Greg ZanteCFOSell50,309$42.75$2,150,709.75165,259View SEC Filing Icon  
1/6/2025Marianna ManciniCOOSell54,215$42.75$2,317,691.25374,134View SEC Filing Icon  
11/8/2024Lawson MacartneyDirectorSell2,000$68.67$137,340.0047,965View SEC Filing Icon  
10/28/2024Greg ZanteCFOSell131,687$76.61$10,088,541.07149,366View SEC Filing Icon  
10/25/2024Sarah Kathryn RouanDirectorSell11,000$80.89$889,790.009,500View SEC Filing Icon  
9/20/2024Brian LianCEOSell216,130$70.83$15,308,487.902,304,927View SEC Filing Icon  
9/20/2024J. Matthew SingletonDirectorSell10,300$69.50$715,850.009,500View SEC Filing Icon  
8/21/2024Brian LianCEOSell1,000$69.90$69,900.002,354,927View SEC Filing Icon  
8/21/2024J. Matthew SingletonDirectorSell5,700$69.72$397,404.009,500View SEC Filing Icon  
8/19/2024Brian LianCEOSell112,870$65.80$7,426,846.002,354,927View SEC Filing Icon  
8/19/2024J. Matthew SingletonDirectorSell16,000$62.22$995,520.009,500View SEC Filing Icon  
8/14/2024J. Matthew SingletonDirectorSell20,786$57.53$1,195,818.589,500View SEC Filing Icon  
7/30/2024Brian LianCEOSell115,859$57.58$6,671,161.222,354,927View SEC Filing Icon  
7/30/2024Marianna ManciniCOOSell18,026$57.13$1,029,825.38362,149View SEC Filing Icon  
5/3/2024Greg ZanteCFOSell66,756$74.69$4,986,005.64174,854View SEC Filing Icon  
5/1/2024Marianna ManciniCOOSell281,425$78.66$22,136,890.50348,508View SEC Filing Icon  
2/8/2024Brian LianCEOSell269,079$26.87$7,230,152.732,184,882View SEC Filing Icon  
2/8/2024Sarah Kathryn RouanDirectorSell25,000$28.05$701,250.00View SEC Filing Icon  
1/30/2024Brian LianCEOSell35,000$23.95$838,250.002,264,882View SEC Filing Icon  
1/19/2024Sarah Kathryn RouanDirectorSell30,000$23.05$691,500.00View SEC Filing Icon  
1/4/2024Greg ZanteCFOSell15,000$17.90$268,500.00180,730View SEC Filing Icon  
5/16/2023Charles A. Rowland, Jr.DirectorSell40,000$25.00$1,000,000.0030,000View SEC Filing Icon  
5/1/2023Brian LianCEOSell45,000$22.45$1,010,250.002,197,963View SEC Filing Icon  
4/24/2023Lawson MacartneyDirectorSell16,000$22.00$352,000.0047,965View SEC Filing Icon  
4/19/2023Brian LianCEOSell35,000$21.45$750,750.002,242,963View SEC Filing Icon  
4/17/2023Brian LianCEOSell155,000$20.45$3,169,750.002,277,963View SEC Filing Icon  
4/17/2023Greg ZanteCFOSell7,500$20.00$150,000.00149,279View SEC Filing Icon  
4/17/2023Lawson MacartneyDirectorSell20,786$20.00$415,720.0047,965View SEC Filing Icon  
4/17/2023Marianna ManciniCOOSell12,500$20.00$250,000.00287,763View SEC Filing Icon  
4/13/2023Brian LianCEOSell79,336$18.45$1,463,749.202,307,963View SEC Filing Icon  
4/11/2023Greg ZanteCFOSell56,295$18.00$1,013,310.00149,279View SEC Filing Icon  
4/3/2023Brian LianCEOSell22,000$17.85$392,700.002,232,963View SEC Filing Icon  
4/3/2023Greg ZanteCFOSell30,911$18.00$556,398.00147,778View SEC Filing Icon  
3/31/2023Brian LianCEOSell67,970$17.45$1,186,076.502,254,963View SEC Filing Icon  
3/30/2023Greg ZanteCFOSell131,029$17.00$2,227,493.00147,778View SEC Filing Icon  
3/29/2023Marianna ManciniCOOSell41,242$16.00$659,872.00261,895View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Viking Therapeutics (NASDAQ:VKTX)

76.03% of Viking Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VKTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Viking Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/6/2026GPS Wealth Strategies Group LLC803$28K0.0%-75.6%0.001%Search for SEC Filing on Google Icon
2/6/2026Keudell Morrison Wealth Management5,950$0.21M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/6/2026Leonteq Securities AG13,861$0.49M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/6/2026IFP Advisors Inc61,678$2.17M0.0%+1.7%0.055%Search for SEC Filing on Google Icon
2/6/2026PSP Research LLC14,714$0.52M0.5%N/A0.013%Search for SEC Filing on Google Icon
2/6/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.144,557$5.09M0.2%N/A0.128%Search for SEC Filing on Google Icon
2/6/2026PNC Financial Services Group Inc.7,853$0.28M0.0%+38.1%0.007%Search for SEC Filing on Google Icon
2/6/2026GSA Capital Partners LLP31,922$1.12M0.1%+103.5%0.028%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB35,700$1.26M0.0%-4.3%0.032%Search for SEC Filing on Google Icon
2/6/2026Profund Advisors LLC55,883$1.97M0.1%+35.9%0.049%Search for SEC Filing on Google Icon
2/6/2026HighTower Advisors LLC7,533$0.27M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/5/2026Dana Investment Advisors Inc.55,993$1.97M0.1%-15.1%0.050%Search for SEC Filing on Google Icon
2/5/2026DNB Asset Management AS27,376$0.96M0.0%+20.5%0.024%Search for SEC Filing on Google Icon
2/4/2026Independent Advisor Alliance10,182$0.36M0.0%-7.4%0.009%Search for SEC Filing on Google Icon
2/4/2026Englebert Financial Advisers LLC11,761$0.41M0.5%N/A0.010%Search for SEC Filing on Google Icon
2/4/2026WealthTrust Asset Management LLC6,162$0.22M0.2%N/A0.005%Search for SEC Filing on Google Icon
2/3/2026Farmers & Merchants Investments Inc.11,875$0.42M0.0%-5.9%0.011%Search for SEC Filing on Google Icon
2/3/2026Channel Wealth LLC75,475$2.66M0.7%N/A0.067%Search for SEC Filing on Google Icon
2/3/2026International Assets Investment Management LLC5,927$0.21M0.0%-44.2%0.005%Search for SEC Filing on Google Icon
2/3/2026RFG Advisory LLC143,560$5.05M0.1%+19.4%0.127%Search for SEC Filing on Google Icon
2/3/2026SBI Securities Co. Ltd.17,104$0.60M0.0%-27.6%0.015%Search for SEC Filing on Google Icon
2/2/2026Montag A & Associates Inc.5,013$0.18M0.0%-24.3%0.004%Search for SEC Filing on Google Icon
2/2/2026MN Wealth Advisors LLC30,259$1.07M0.5%+12.1%0.027%Search for SEC Filing on Google Icon
2/2/2026Fifth Third Bancorp1,077$38K0.0%+169.3%0.001%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.156,653$5.51M0.1%-15.0%0.139%Search for SEC Filing on Google Icon
1/30/2026Sigma Planning Corp7,760$0.27M0.0%N/A0.007%Search for SEC Filing on Google Icon
1/30/2026North Star Investment Management Corp.1,573$55K0.0%-47.8%0.001%Search for SEC Filing on Google Icon
1/30/2026Activest Wealth Management1,318$46K0.0%-37.1%0.001%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D57,120$2.01M0.0%-31.1%0.051%Search for SEC Filing on Google Icon
1/30/2026PVG Asset Management Corp11,699$0.41M0.9%-12.5%0.010%Search for SEC Filing on Google Icon
1/30/2026Wealthfront Advisers LLC12,321$0.43M0.0%-3.8%0.011%Search for SEC Filing on Google Icon
1/30/2026M&T Bank Corp15,007$0.53M0.0%+51.3%0.013%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank3,460$0.12M0.0%-15.3%0.003%Search for SEC Filing on Google Icon
1/29/2026S.A. Mason LLC2,900$0.10M0.0%N/A0.003%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA752,732$26.48M0.0%-37.1%0.666%Search for SEC Filing on Google Icon
1/29/2026Sanctuary Advisors LLC28,849$1.02M0.0%N/A0.026%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.9,984,487$351.25M0.0%-0.1%8.833%Search for SEC Filing on Google Icon
1/29/2026Concurrent Investment Advisors LLC281,052$9.89M0.1%+1,624.0%0.249%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System29,654$1.04M0.0%-6.0%0.026%Search for SEC Filing on Google Icon
1/28/2026HB Wealth Management LLC10,710$0.38M0.0%N/A0.009%Search for SEC Filing on Google Icon
1/28/2026M&T Bank Corp69,914$2.46M0.0%+605.1%0.062%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH26,741$0.94M0.0%N/A0.024%Search for SEC Filing on Google Icon
1/27/2026TD Waterhouse Canada Inc.1,400$49K0.0%+250.0%0.001%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 36,777$1.29M0.0%+2.7%0.033%Search for SEC Filing on Google Icon
1/27/2026Bayforest Capital Ltd6,685$0.24M0.2%N/A0.006%Search for SEC Filing on Google Icon
1/27/2026Institute for Wealth Management LLC.107,913$3.80M0.4%+3.9%0.095%Search for SEC Filing on Google Icon
1/26/2026CWM LLC9,799$0.35M0.0%+143.6%0.009%Search for SEC Filing on Google Icon
1/26/2026PFG Investments LLC7,005$0.25M0.0%-11.7%0.006%Search for SEC Filing on Google Icon
1/23/2026Farther Finance Advisors LLC15,757$0.55M0.0%+677.4%0.014%Search for SEC Filing on Google Icon
1/23/2026Oak Ridge Investments LLC11,586$0.41M0.0%-5.1%0.010%Search for SEC Filing on Google Icon
1/23/2026Assetmark Inc.3,408$0.12M0.0%-72.5%0.003%Search for SEC Filing on Google Icon
1/23/2026U.S. Capital Wealth Advisors LLC69,030$2.43M0.1%-26.7%0.061%Search for SEC Filing on Google Icon
1/23/2026Choreo LLC6,909$0.24M0.0%N/A0.006%Search for SEC Filing on Google Icon
1/22/2026MH & Associates Securities Management Corp ADV43,634$1.54M1.3%N/A0.039%Search for SEC Filing on Google Icon
1/21/2026Prime Capital Investment Advisors LLC5,825$0.21M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/21/2026Raleigh Capital Management Inc.945$33K0.0%+58.0%0.001%Search for SEC Filing on Google Icon
1/20/2026Ethos Financial Group LLC14,012$0.49M0.0%+27.7%0.012%Search for SEC Filing on Google Icon
1/20/2026Harbor Capital Advisors Inc.16,769$0.59M0.0%+3.7%0.015%Search for SEC Filing on Google Icon
1/16/2026Formidable Asset Management LLC69,885$2.46M0.4%+44.8%0.062%Search for SEC Filing on Google Icon
1/16/2026Blue Trust Inc.812$29K0.0%-38.6%0.001%Search for SEC Filing on Google Icon
1/16/2026Banque Pictet & Cie SA35,026$1.23M0.0%+281.7%0.031%Search for SEC Filing on Google Icon
1/16/2026Compagnie Lombard Odier SCmA16,245$0.57M0.0%-19.8%0.014%Search for SEC Filing on Google Icon
1/16/2026Tema Etfs LLC14,047$0.49M0.0%N/A0.012%Search for SEC Filing on Google Icon
1/15/2026Lodestone Wealth Management LLC1,105$39K0.0%N/A0.001%Search for SEC Filing on Google Icon
1/15/2026Royal Fund Management LLC43,152$1.52M0.1%N/A0.038%Search for SEC Filing on Google Icon
1/15/2026Lewis Asset Management LLC61,890$2.18M0.9%+10.7%0.055%Search for SEC Filing on Google Icon
1/14/2026Exchange Traded Concepts LLC55,565$1.96M0.0%-6.2%0.049%Search for SEC Filing on Google Icon
1/12/2026Meadowbrook Wealth Management LLC37,205$1.31M1.5%N/A0.033%Search for SEC Filing on Google Icon
1/12/2026E. Ohman J or Asset Management AB12,116$0.43M0.0%N/A0.011%Search for SEC Filing on Google Icon
1/9/2026Murphy Middleton Hinkle & Parker Inc.1,706$60K0.0%N/A0.002%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC69,613$2.45M0.0%-27.3%0.062%Search for SEC Filing on Google Icon
1/9/2026180 Wealth Advisors LLC5,807$0.20M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC15,594$0.50M0.0%+4.7%0.014%Search for SEC Filing on Google Icon
1/8/2026Profit Investment Management LLC17,995$0.63M2.6%-76.5%0.016%Search for SEC Filing on Google Icon
1/7/2026MassMutual Private Wealth & Trust FSB10,625$0.37M0.0%+2,400.0%0.009%Search for SEC Filing on Google Icon
1/7/2026Harbour Capital Advisors LLC13,010$0.46M0.1%N/A0.012%Search for SEC Filing on Google Icon
1/7/2026Significant Wealth Partners LLC6,986$0.25M0.3%-53.8%0.006%Search for SEC Filing on Google Icon
1/5/2026GAMMA Investing LLC1,195$42K0.0%+71.0%0.001%Search for SEC Filing on Google Icon
12/31/2025PVG Asset Management Corp13,364$0.35M1.3%+18.7%0.012%Search for SEC Filing on Google Icon
12/15/2025FNY Investment Advisers LLC11,628$0.31M0.1%+45.5%0.010%Search for SEC Filing on Google Icon
12/2/2025IFP Advisors Inc58,496$1.65M0.0%+12.7%0.052%Search for SEC Filing on Google Icon
11/20/2025Wilmington Savings Fund Society FSB10,000$0.26M0.0%+42.9%0.009%Search for SEC Filing on Google Icon
11/18/2025Advisory Services Network LLC36,192$0.95M0.0%+90.1%0.032%Search for SEC Filing on Google Icon
11/17/2025Financial Engines Advisors L.L.C.14,852$0.39M0.0%-38.0%0.013%Search for SEC Filing on Google Icon
11/17/2025NewEdge Advisors LLC16,608$0.44M0.0%-6.5%0.015%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP301,994$7.94M0.0%+0.3%0.267%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd41,915$1.10M0.1%+15.8%0.037%Search for SEC Filing on Google Icon
11/17/2025Wasatch Advisors LP128,467$3.38M0.0%-51.0%0.114%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC13,738$0.36M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/17/2025Quadcap Wealth Management LLC8,388$0.22M0.0%-20.4%0.007%Search for SEC Filing on Google Icon
11/17/2025Northwestern Mutual Wealth Management Co.1,362$36K0.0%-35.4%0.001%Search for SEC Filing on Google Icon
11/17/2025MASO CAPITAL PARTNERS Ltd25,000$0.66M1.1%+66.7%0.022%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,195$0.26M0.0%+32.5%0.009%Search for SEC Filing on Google Icon
11/17/2025Kintayl Capital LP100,191$2.63M1.6%-22.7%0.089%Search for SEC Filing on Google Icon
11/17/2025Lido Advisors LLC21,843$0.57M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/17/2025Gotham Asset Management LLC169,683$4.46M0.0%N/A0.150%Search for SEC Filing on Google Icon
11/17/2025Granahan Investment Management LLC189,529$4.98M0.2%-37.9%0.168%Search for SEC Filing on Google Icon
11/17/2025Cinctive Capital Management LP13,798$0.36M0.0%-14.9%0.012%Search for SEC Filing on Google Icon
11/17/2025Baker BROS. Advisors LP366,083$9.62M0.1%N/A0.324%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE578,268$15.20M0.0%+10.2%0.512%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Viking Therapeutics logo
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
Read More on Viking Therapeutics

Today's Range

Now: $28.44
Low: $26.89
High: $28.47

50 Day Range

MA: $33.83
Low: $26.29
High: $38.57

52 Week Range

Now: $28.44
Low: $18.92
High: $43.15

Volume

3,684,643 shs

Average Volume

3,183,297 shs

Market Capitalization

$3.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Who are the company insiders with the largest holdings of Viking Therapeutics?

Viking Therapeutics' top insider shareholders include:
  1. Brian Lian (CEO)
  2. Marianna Mancini (COO)
  3. Greg Zante (CFO)
  4. Matthew W Foehr (Director)
  5. Lawson Macartney (Director)
  6. Charles A Rowland Jr (Director)
  7. J Matthew Singleton (Director)
  8. Sarah Kathryn Rouan (Director)
Learn More about top insider investors at Viking Therapeutics.

Who are the major institutional investors of Viking Therapeutics?

Viking Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 8.83%
  2. Pictet Asset Management Holding SA — 0.67%
  3. Concurrent Investment Advisors LLC — 0.25%
  4. Oppenheimer & Co. Inc. — 0.14%
  5. Fideuram Intesa Sanpaolo Private Banking S.P.A. — 0.13%
  6. RFG Advisory LLC — 0.13%
Learn More about top institutional investors of Viking Therapeutics stock.

Which major investors are selling Viking Therapeutics stock?

In the previous quarter, VKTX stock was sold by these institutional investors:
  1. Pictet Asset Management Holding SA
  2. Profit Investment Management LLC
  3. IMC Chicago LLC
  4. Oppenheimer & Co. Inc.
  5. SG Americas Securities LLC
  6. State of New Jersey Common Pension Fund D
  7. U.S. Capital Wealth Advisors LLC
  8. Vanguard Group Inc.
Within the last year, company insiders that have sold Viking Therapeutics company stock include:
  1. Brian Lian (CEO)
  2. Marianna Mancini (COO)
  3. Greg Zante (CFO)
  4. Matthew W Foehr (Director)
  5. Lawson Macartney (Director)
Learn More investors selling Viking Therapeutics stock.

Which major investors are buying Viking Therapeutics stock?

Within the previous quarter, VKTX stock was purchased by institutional investors including:
  1. Concurrent Investment Advisors LLC
  2. Fideuram Intesa Sanpaolo Private Banking S.P.A.
  3. Channel Wealth LLC
  4. M&T Bank Corp
  5. MH & Associates Securities Management Corp ADV
  6. Royal Fund Management LLC
  7. Meadowbrook Wealth Management LLC
  8. Sanctuary Advisors LLC